319 related articles for article (PubMed ID: 30869743)
1. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
[TBL] [Abstract][Full Text] [Related]
2. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
[TBL] [Abstract][Full Text] [Related]
5. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis.
Li M; Wang T; Wen P; Wang X; Wu C
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.
Yavuz AA; Topkan E; Onal C; Yavuz MN
J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
[TBL] [Abstract][Full Text] [Related]
9. Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.
Witlox WJA; Ramaekers BLT; Lacas B; Le Pechoux C; Pignon JP; Sun A; Wang SY; Hu C; Redman M; van der Noort V; Li N; Guckenberger M; van Tinteren H; Groen HJM; Joore MA; De Ruysscher DKM
Radiother Oncol; 2021 May; 158():40-47. PubMed ID: 33587968
[TBL] [Abstract][Full Text] [Related]
10. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.
Gore EM; Hu C; Sun AY; Grimm DF; Ramalingam SS; Dunlap NE; Higgins KA; Werner-Wasik M; Allen AM; Iyengar P; Videtic GMM; Hales RK; McGarry RC; Urbanic JJ; Pu AT; Johnstone CA; Stieber VW; Paulus R; Bradley JD
J Thorac Oncol; 2017 Oct; 12(10):1561-1570. PubMed ID: 28648948
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
Park HS; Decker RH; Wilson LD; Yu JB
Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
[TBL] [Abstract][Full Text] [Related]
13. The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer.
Precival C; Landy M; Poole C; Mullaney L
Anticancer Res; 2018 Jan; 38(1):7-14. PubMed ID: 29277750
[TBL] [Abstract][Full Text] [Related]
14. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J
JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
[TBL] [Abstract][Full Text] [Related]
17. [Present role of prophylactic cranial irradiation].
Le Péchoux C; Al Mohkles H; Dhermain F
Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
[TBL] [Abstract][Full Text] [Related]
18. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
19. Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.
Boggs DH; Robins HI; Langer CJ; Traynor AM; Berkowitz MJ; Mehta MP
Clin Lung Cancer; 2014 Nov; 15(6):433-40. PubMed ID: 25069747
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis.
Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T
J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]